NNSA to help fund Shine Technologies new medical isotope production facility

The NNSA intends to grant SHINE Technologies cost-share funding to build and operate a new facility for producing the medical isotope molybdenum-99 (Mo-99) without the use of highly-enriched uranium, according to a March 4 filing in the Federal Register.
The agency…

In This Issue

More on This Topic